Use of illuminance as a guide to effective light delivery during daylight photodynamic therapy in the U.K.
- 5 April 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 176 (6) , 1607-1616
Abstract
Daylight PDT (dPDT) is an effective and nearly painless treatment for field-change actinic keratosis. Measuring the protoprophyrin-IX (PpIX)-weighted exposure dose can give an indication of when conditions are most viable for effective dPDT. It would be advantageous for practitioners if more detailed information of exposure dose and appropriate treatment conditions were available. Where sophisticated measurement equipment is unavailable, simpler and more cost-effective methods of dose measurement are desirable. To devise a model whereby illuminance data can be converted into PpIX-weighted exposure dose, and to use this model to estimate appropriate times for dPDT across the UK and Ireland. Spectral irradiance data were analysed to obtain a conversion model for illuminance to PpIX-weighted dose. This model was applied to historic illuminance data from nine sites to obtain PpIX-weighted dose across the UK and Ireland. Temperature data and an analysis of conservatory-based dPDT were also considered. A distribution of the expected PpIX-weighted dose across the nine locations is presented; however, the temperature data showed that it could be too cold for dPDT even when there is sufficient light exposure. Conservatory-based dPDT could extend the times in the year for possible treatment. This proposed conversion model provides a means of using an illuminance reading to calculate the PpIX-weighted exposure dose. Dosimetry of dPDT may be carried out simply and at low cost using the presented method, however the results presented may be used as a guide for those considering dPDT, without the need to conduct measurements themselves.Keywords
Funding Information
- Medi-lase
- Alfred Stewart Trust
This publication has 21 references indexed in Scilit:
- Patient satisfaction in the photodynamic therapy clinicPhotodermatology, Photoimmunology & Photomedicine, 2015
- Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator‐blinded, controlled, phase III study throughout EuropeJournal of the European Academy of Dermatology and Venereology, 2015
- Practical approach to the use of daylight photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: a European consensusJournal of the European Academy of Dermatology and Venereology, 2015
- A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalpBritish Journal of Dermatology, 2011
- A review of pain experienced during topical photodynamic therapy—Our experience in DundeePhotodiagnosis and Photodynamic Therapy, 2011
- Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded studyBritish Journal of Dermatology, 2008
- Light distribution and calibration of commercial PDT LED arraysPhotochemical & Photobiological Sciences, 2005
- Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology GroupBritish Journal of Dermatology, 2002
- SHORT COMMUNICATIONPhotodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking techniqueBritish Journal of Dermatology, 2000
- 5-Aminolevulinic acid-based photodynamic therapyCancer, 1997